Gilead HIV Drug Liability Theory Gets California Top Court Look California’s top court agreed Wednesday to consider the viability of a groundbreaking liability theory used by thousands of plaintiffs against Gilead Sciences Inc. over its HIV medications. 05/1/2024 - 1:33 pm | View Link
FDA approves Gilead Sciences’ Biktarvy label update for pregnant adults with HIV Gilead Sciences has received permission from the Food and Drug Administration for an updated label with additional data reinforcing the safety and efficacy profile of Biktarvy (bictegravir 50 ... 04/30/2024 - 1:00 pm | View Link
Gilead Sciences: Hold Rating Justified Amid Stable Outlook and Upcoming Oncology Catalysts Analyst Salveen Richter of Goldman Sachs maintained a Hold rating on Gilead Sciences (GILD – Research Report), with a price target of ... 04/29/2024 - 11:56 pm | View Link
Gilead Sciences: First-Quarter Results Beat Estimates The biopharmaceutical giant topped its earnings and revenue estimates thanks to strong sales of its HIV, liver disease, and oncology treatments. 04/29/2024 - 9:55 am | View Link
Gilead Sciences: Hold Rating with Cautious Outlook Amidst Market Challenges and Growth Uncertainties Emily Field, an analyst from Barclays, maintained the Hold rating on Gilead Sciences (GILD – Research Report). The associated price ... 04/28/2024 - 10:46 pm | View Link
Gilead Sciences, Inc. At Gilead, we’re committed to creating a healthier world for everyone – no matter the challenges ahead of us. For more than 30 years, we’ve pursued the impossible, chased it down, tackled it for answers and surrounded it for a way in. 04/29/2024 - 5:17 am | View Link
About Us | Gilead At Gilead, we set – and achieve – bold ambitions to create a healthier world for all people. From our pioneering virology medicines to our growing impact in oncology, we're delivering innovations once thought impossible in medicine. 04/29/2024 - 1:06 am | View Link
Gilead Gilead or Gilad (/ ˈ ɡ ɪ l i ə d /; Hebrew: גִּלְעָד Gilʿāḏ, Arabic: جلعاد, Ǧalʻād, Jalaad) is the ancient, historic, biblical name of the mountainous northern part of the region of Transjordan. 04/28/2024 - 11:19 pm | View Link
Gilead (novel) Gilead is a novel written by Marilynne Robinson published in 2004. It won the 2005 Pulitzer Prize for Fiction and the National Book Critics Circle Award. It is Robinson's second novel, following Housekeeping (1980). 04/28/2024 - 8:34 pm | View Link
Gilead Sciences Gilead Sciences, Inc. (/ ˈ ɡ ɪ l i ə d /) is an American biopharmaceutical company headquartered in Foster City, California that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir. 04/28/2024 - 7:58 pm | View Link
Everyone should be involved in equity issues, from the CEO to the front-line staff.
In today’s workplace, equity for all should not be relegated to the mantra of the month or treated as a “nice to have” for organizations. A recent Great Place To Work study shows that companies that build a “for all” or “innovation by all” culture generated 5.5 more revenue growth compared to less-inclusive peers.
Few colleges are preparing students for how to survive in today’s economy, which doesn’t always revolve around 9-to-5 jobs. Some teachers want to change that.
Fletcher Medler, a student at Berklee College of Music, is enrolled in “The General Business Gig,” a course dedicated to teaching musicians how to survive in the gig economy.
The lawsuit blames major cellular carriers for failure to report outages to emergency agencies.
Had emergency responders known about widespread cellphone outages during the height of last summer’s deadly Maui wildfires, they would have used other methods to warn about the disaster, county officials said in a lawsuit. Alerts the county sent to cellphones warning people to immediately evacuate were never received, unbeknownst to the county, the lawsuit said.
The buyback announcement comes as iPhone sales have declined, although the tech giant still beat analysts’ earnings estimates this week.
Yesterday, Apple revealed earnings for its fiscal second quarter. While iPhone sales were down almost 10%, the company’s revenues and earnings per share beat expectations, albeit slightly. On the company’s earnings call, in addition to execs talking up the prospects of Apple’s AI plans, the company also announced another share buyback—this one the largest in U.
U. S. District Judge Amit Mehta questioned the likelihood of any other company’s ability to have the resources needed to compete against Google’s search engine.
The judge overseeing a pivotal antitrust trial focused on whether Google is stifling competition and innovation repeatedly indicated Thursday that he believes it would be difficult for a formidable rival search engine to emerge.
The USDA has issued a recall notice for ground beef distributed by Cargill Meat Solutions. Here’s what to know:
The U. S. Department of Agriculture’s Food Safety and Inspection Service (FSIS) has issued a recall notice for over 16,000 pounds of ground beef due to fears that it may be contaminated with E.